Ian F. Smith, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 75,000 shares at $142.40 ($10.9M) on 2017-10-31, disclosed to the SEC on 2017-10-31.
Scheduled sale ($10.9M) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.40 | 1,700 | $242K | 2.2% |
| 2 | $143.47 | 5,200 | $746K | 6.9% |
| 3 | $144.47 | 32,945 | $4.8M | 43.7% |
| 4 | $145.26 | 22,464 | $3.3M | 30.0% |
| 5 | $146.39 | 5,200 | $761K | 7.0% |
| 6 | $147.40 | 3,500 |
| $516K |
| 4.7% |
| 7 | $148.26 | 3,791 | $562K | 5.2% |
| 8 | $149.34 | 200 | $30K | 0.3% |
| Total | $145.06 avg | 75,000 | $10.9M | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |